fda glp-1 compounding enforcement november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA Sends Warning Letters to

Heart patients saved about 0.25 kilograms of carbon dioxide emissions per person annually when taking GLP-1 drugs, because they were less likely to require hospitalization, researchers found

Different laser types are chosen based on skin tone and the cause of darkness, which is especially important for Pakistani and South Asian skin , where incorrect laser settings can worsen pigmentation

Air bubbles are not dangerous for subcutaneous injections

BPC-157 exerts anti-inflammatory effects through multiple mechanisms including modulation of nitric oxide signaling, reduction of pro-inflammatory cytokines, and stabilization of cellular integrity during metabolic stress

Florida Surgery and Weight Loss Center provides medically supervised weight loss care and can help patients understand dosing instructions, pharmacy labeling, and treatment planning

Levocarnitine (L-carnitine) is a component of food and is widely distributed in nature